The interlacing anticancer effect of pharmacologic ascorbate, chloroquine, and resveratrol
BioFactors · 2024
DOI: 10.1002/biof.2050 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, 2024. Verfasst von Kinga Makk-Merczel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry and Molecular Biology, Department of Applied Biotechnology and Food Science, Budapest University of Technology and Economi…. Hauptthemen laut MEDLINE: Resveratrol, Chloroquine, Ascorbic Acid, Reactive Oxygen Species. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nemzeti Kutatási Fejlesztési és Innovációs Hivatal, New National Excellence Program.
Abstract (Originalsprache)
Currently, a diagnosis with KRAS mutant pancreatic ductal adenocarcinoma (PDAC) means a death warrant, so finding efficient therapeutic options is a pressing issue. Here, we presented that pharmacologic ascorbate, chloroquine and resveratrol co‐treatment exerted a synergistic cytotoxic effect on PDAC cell lines. The observed synergistic cytotoxicity was a general feature in all investigated cancer cell lines independent of the KRAS mutational status and seems to be independent of the autophagy inhibitory effect of chloroquine. Furthermore, it seems that apoptosis and necroptosis are also not likely to play any role in the cytotoxicity of chloroquine. Both pharmacologic ascorbate and resveratrol caused double‐strand DNA breaks accompanied by cell cycle arrest. It seems resveratrol‐induced cytotoxicity is independent of reactive oxygen species (ROS) generation and accompanied by a significant elevation of caspase‐3/7 activity, while pharmacologic ascorbate‐induced cytotoxicity shows strong ROS dependence but proved to be caspase‐independent. Our results are particularly important since ascorbate and resveratrol are natural compounds without significant harmful effects on normal cells, and chloroquine is a known antimalarial drug that can easily be repurposed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biochemistry and Molecular Biology, Department of Applied Biotechnology and Food Science, Budapest University of Technology and Economics, Budapest, Hungary.
- Biotechnology Model Laboratory, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Budapest, Hungary.
ORCID-Profile: András Szarka
Förderung
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
- New National Excellence Program
Zitieren
APA
Makk-Merczel, K., Varga, D., Hajdinák, P., & Szarka, A. (2024). The interlacing anticancer effect of pharmacologic ascorbate, chloroquine, and resveratrol. BioFactors. https://doi.org/10.1002/biof.2050
Vancouver
Makk-Merczel K, Varga D, Hajdinák P, Szarka A. The interlacing anticancer effect of pharmacologic ascorbate, chloroquine, and resveratrol. BioFactors. 2024. doi:10.1002/biof.2050
BibTeX
@article{MakkMerczel2024,
author = {Makk-Merczel, Kinga and Varga, Dóra and Hajdinák, Péter and Szarka, András},
title = {The interlacing anticancer effect of pharmacologic ascorbate, chloroquine, and resveratrol},
journal = {BioFactors},
year = {2024},
doi = {10.1002/biof.2050}
}
EUVIMED